絞り込み

16731

広告

Safety and Efficacy of Edoxaban, an Oral Factor Xa Inhibitor, Versus Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty: The STARS E-3 Trial.

著者 Fuji T , Wang CJ , Fujita S , Kawai Y , Nakamura M , Kimura T , Ibusuki K , Ushida H , Abe K , Tachibana S
Thromb Res.2014 Sep 21 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (218view , 0users)

Full Text Sources

Medical

This phase 3 trial compared the safety and efficacy of edoxaban, an oral direct factor Xa inhibitor, with enoxaparin sodium (enoxaparin) for thromboprophylaxis after total knee arthroplasty (TKA) in patients in Japan and Taiwan.
PMID: 25294589 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード